Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.4, was added and the previous v3.5.3 tag was removed, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-05-18T13:28:04.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, reflecting a site release/update rather than any change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-27T07:43:39.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-20T03:28:33.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:57:11.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T01:41:16.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1. This appears to be a minor version update with no impact on the study details or user interactions.
    Difference
    0.0%
    Check dated 2026-02-14T12:43:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.